glp-1 miracle drug medications like Wegovy and Ozempic have been drugs for patients seeking to treat obesity and type 2 diabetes. However, their high costs have made them inaccessible for many patients, prompting Hims & Hers, and the

It occupies a different mechanistic category from cognitive peptides like Semax or energy peptides like NAD+, which means there is no redundancy in combining them

GLP-1 receptor agonists augment glucose-dependent insulin release and reduce glucagon secretion and gastric emptying while inhibiting food intake and reducing body weight

DOI: Published online: April 4, 2017 Department of Pathology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea 1 Department of Neurosurgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea 2 Department of Radiology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea 3 Department of Pathology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea Corresponding Author Se Hoon Kim, MD Department of Pathology, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea Tel: +82-2-2228-1764 Fax: +82-2-362-0860 E-mail: [email protected] *Sung-eun Choi and Yoon Jin Cha contributed equally to this work

Liposomal glutathione as a promising candidate for immunological rheumatoid arthritis therapy Weschawalit, S., et al